WellPoint Hopes To Curb Relenza Costs By Pushing Flu Vaccination
Executive Summary
WellPoint Health Networks is encouraging flu vaccinations in 280,000 letters to members, as part of a campaign to limit use of Glaxo Wellcome's influenza treatment Relenza.
You may also be interested in...
Relenza And Tamiflu May Add Only 10[cents] PMPM Annually For HMOs, Study Says
The new influenza treatments Relenza and Tamiflu could cost managed care organizations a yearly estimated average of 10[cents] per member per month if visits for influenza do not increase, an Advance Paradigm study projects.
Relenza And Tamiflu May Add Only 10[cents] PMPM Annually For HMOs, Study Says
The new influenza treatments Relenza and Tamiflu could cost managed care organizations a yearly estimated average of 10[cents] per member per month if visits for influenza do not increase, an Advance Paradigm study projects.
Tamiflu DTC Ads Should Encourage Flu Vaccination, FDA's Jolson Suggests
Direct-to-consumer advertising for Roche/Gilead's Tamiflu should emphasize the importance of influenza vaccination, FDA Antiviral Drug Products Division Director Heidi Jolson, MD, said in a memo explaining FDA's rationale for approving the flu treatment.